GSK press releases Follow GSK to advance mRNA seasonal flu vaccine candidate to phase III following positive phase II data Phase III trial to start in September 2026 https://www.gsk.com/en-gb/media/press-releases/gsk-to-advance-mrna-seasonal-flu-vaccine-candidate-to-phase-iii-following-positive-phase-ii-data/ gsk.com
